2006
DOI: 10.1055/s-2006-933785
|View full text |Cite
|
Sign up to set email alerts
|

Phase II-Studie zur Behandlung des vorbehandelten, fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms (NSCLC) mit Sorafenib (BAY 43–9006)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2006
2006
2006
2006

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 0 publications
0
0
0
Order By: Relevance